State Street Corp Purchases 19,796 Shares of Analogic Corporation (ALOG)
State Street Corp grew its position in shares of Analogic Corporation (NASDAQ:ALOG) by 6.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 345,329 shares of the medical research company’s stock after purchasing an additional 19,796 shares during the quarter. State Street Corp owned approximately 2.77% of Analogic Corporation worth $25,086,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. Citadel Advisors LLC boosted its stake in shares of Analogic Corporation by 88.8% during the second quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock valued at $9,363,000 after purchasing an additional 60,614 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of Analogic Corporation in the first quarter worth approximately $1,252,000. Vanguard Group Inc. lifted its stake in shares of Analogic Corporation by 3.1% in the second quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after acquiring an additional 34,765 shares during the period. Geode Capital Management LLC lifted its stake in shares of Analogic Corporation by 8.4% in the first quarter. Geode Capital Management LLC now owns 104,722 shares of the medical research company’s stock worth $7,947,000 after acquiring an additional 8,092 shares during the period. Finally, SG Americas Securities LLC lifted its stake in shares of Analogic Corporation by 470.7% in the second quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock worth $554,000 after acquiring an additional 6,284 shares during the period. 97.30% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Analogic Corporation (ALOG) opened at $80.30 on Tuesday. The company has a market capitalization of $998.77, a P/E ratio of 47.62, a PEG ratio of 4.08 and a beta of 0.85. Analogic Corporation has a 1-year low of $66.00 and a 1-year high of $95.85.
Several equities analysts have issued reports on ALOG shares. Zacks Investment Research raised Analogic Corporation from a “hold” rating to a “buy” rating and set a $93.00 price target on the stock in a research note on Tuesday, October 10th. Jefferies Group LLC reissued a “hold” rating and issued a $75.00 price target on shares of Analogic Corporation in a research note on Wednesday, September 20th. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Analogic Corporation currently has a consensus rating of “Hold” and a consensus target price of $85.25.
ILLEGAL ACTIVITY NOTICE: This story was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2017/11/14/state-street-corp-purchases-19796-shares-of-analogic-corporation-alog.html.
Analogic Corporation Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.